Showing results (51-60 of 205) with videos related to
Sort By:
Pageof 21
Biochemical and Biophysical Research Communications|December 31, 1990
Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activityG Freiss, H Rochefort, F VignonMolecular Endocrinology (Baltimore, Md.)|March 1, 1989
Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cellsV Cavailles, M Garcia, H RochefortEndocrinology|September 1, 1995
Insulin-like growth factors (IGFs) stimulate the release of alpha 1-antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cellsC Confort, H Rochefort, F VignonProceedings of the National Academy of Sciences of the United States of America|January 1, 1993
Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cellsV Cavaillès, P Augereau, H RochefortLa Revue Du Praticien|May 15, 1994
[Estrogen receptors and breast cancer]T Maudelonde, P Pujol, H RochefortBiochemical and Biophysical Research Communications|January 31, 1991
Cathepsin D gene of human MCF7 cells contains estrogen-responsive sequences in its 5' proximal flanking regionV Cavailles, P Augereau, H RochefortCancer Research|November 1, 1981
Estrogenic effects of physiological concentrations of 5-androstene-3 beta, 17 beta-diol and its metabolism in MCF7 human breast cancer cellsJ Adams, M Garcia, H RochefortEnzyme & Protein|January 1, 1996
Alterations and role of human cathepsin D in cancer metastasisH Rochefort, E Liaudet, M GarciaEuropean Journal of Biochemistry|May 15, 1981
5-Bromodeoxyuridine specifically inhibits the synthesis of estrogen-induced proteins in MCF7 cellsM Garcia, B Westley, H RochefortJournal of the National Cancer Institute|January 1, 1992
Inhibition of breast cancer growth by suraminF Vignon, C Prebois, H RochefortPageof 21